Table 3.
Sex steroid hormones | Model 1†
|
Model 2†
|
Model 3§
|
|||
---|---|---|---|---|---|---|
Mean | 95 % CI | Mean | 95 % CI | Mean | 95 % CI | |
Total testosterone (ng/mL) | ||||||
≤3.67 | 276 | 259–293 | 282 | 270–294 | 271 | 256–289 |
3.68–4.64 | 248 | 226–271 | 252 | 227–279 | 245 | 222–270 |
4.65–5.62 | 283 | 260–307 | 281 | 259–306 | 279 | 258–303 |
5.62–6.91 | 276 | 262–291 | 274 | 259–289 | 278 | 262–294 |
>6.91 | 283 | 258–310 | 278 | 257–300 | 291 | 267–317 |
Slope, P-trend* | 0.02 | 0.22 | 0.01 | 0.70 | 0.02 | 0.13 |
Free testosterone (ng/mL) | ||||||
≤0.069 | 277 | 253–304 | 278 | 258–300 | 273 | 252–295 |
0.070–0.092 | 270 | 248–293 | 272 | 245–301 | 269 | 242–298 |
0.093–0.113 | 261 | 244–279 | 263 | 247–280 | 262 | 245–279 |
0.113–0.14 | 280 | 262–298 | 277 | 260–296 | 278 | 261–297 |
>0.14 | 279 | 252–309 | 277 | 254–303 | 283 | 260–309 |
Slope, P-trend* | 0.01 | 0.66 | 0.01 | 0.80 | 0.01 | 0.44 |
Total estradiol (pg/mL) | ||||||
≤28.56 | 292 | 278–306 | 288 | 273–302 | 290 | 274–306 |
28.57–33.29 | 269 | 258–281 | 265 | 252–277 | 265 | 252–278 |
33.30–38.66 | 265 | 249–282 | 269 | 252–288 | 269 | 252–288 |
38.67–46.2 | 287 | 257–320 | 287 | 258–318 | 286 | 257–317 |
>46.2 | 257 | 237–279 | 261 | 242–281 | 259 | 241–279 |
Slope, P-trend* | −0.02 | 0.17 | −0.01 | 0.38 | −0.01 | 0.28 |
Free estradiol (pg/mL) | ||||||
≤0.70 | 280 | 269–292 | 272 | 260–285 | 276 | 262–291 |
0.71–0.85 | 282 | 268–296 | 276 | 263–290 | 278 | 265–292 |
0.86–1.0 | 265 | 244–288 | 266 | 246–288 | 267 | 246–289 |
1.1–1.2 | 281 | 268–295 | 285 | 271–301 | 284 | 270–298 |
>1.2 | 259 | 232–290 | 266 | 240–294 | 262 | 238–288 |
Slope, P-trend* | −0.02 | 0.26 | −0.002 | 0.89 | −0.01 | 0.52 |
SHBG (nmol/L) | ||||||
≤24.0 | 272 | 250–296 | 278 | 255–303 | 282 | 255–311 |
24.1–31.6 | 270 | 253–289 | 274 | 257–292 | 275 | 256–296 |
31.7–40.52 | 270 | 256–284 | 271 | 258–285 | 271 | 258–284 |
40.53–53.5 | 283 | 267–301 | 277 | 263–293 | 275 | 261–290 |
>53.5 | 271 | 252–293 | 262 | 242–285 | 260 | 237–286 |
Slope, P-trend* | 0.005 | 0.67 | −0.01 | 0.51 | −0.02 | 0.39 |
Androstanediol glucuronide (ng/mL) | ||||||
≤6.72 | 275 | 262–289 | 274 | 261–287 | Not applicable | |
6.73–9.68 | 283 | 267–301 | 284 | 268–302 | ||
9.69–12.77 | 256 | 237–277 | 258 | 235–283 | ||
12.78–17.82 | 268 | 252–286 | 270 | 253–287 | ||
>17.82 | 283 | 264–303 | 280 | 262–299 | ||
Slope, P-trend* | 0.002 | 0.88 | 0.001 | 0.96 |
SHBG sex hormone-binding globulin
From a weighted linear regression model of sex steroid hormones on IGF-1 adjusted for age and race/ethnicity
Same as model 1 plus adjustment for body mass index, waist circumference, diabetes, alcohol consumption, cigarette smoking, and physical activity
Same as model 2 plus testosterone, estradiol, and SHBG mutually adjusted, and free testosterone and free estradiol mutually adjusted
Change in IGF-1 concentration in ng/mL per one quintile change in sex steroid hormone concentration